Spencer Kobren Interviews Replicel's CEO Concerning Latest Clinical Trial Results

[mack_435]

3 women patients were elimated due to cells shipped at wrong temperature.

Our of all percentages given total density most important. 6.1% is the average at all 16 patients. Some patients had total density increases in the teens some were below baseline.

The male candidates in the test group were NW 3 - Nw 5. The injections took place were there was some terminal hairs but also some visible thinning, the injections took place in the VERTEX.

In response to people saying that the treatment worked better on animals than humans. 6 months in a human life is years in an animals life, they would respond different than us.

Hope to start the next trail of 50-100 people before year end. Will be doing different doses at different frequencies.

Said they will provide more updates in the future.

Few positives to take forward.

They saw some positive results, enough to warrant moving ahead to the next trail.

Few negatives:

He said, "treatment not going to wrok for everybody" even though I think he meand the treatment not going to work the same for everybody. He also said its a long path way.